🔎 Trials Near Me

Utama › Kanser Paru-paru › Kansas › Kansas City

Kajian klinikal Kanser Paru-paru di Kansas City, KS

11 kajian untuk Kanser Paru-paru sedang mencari peserta di lokasi dalam dan sekitar Kansas City (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
  • Veteran Administration Eastern Kansas Healthcare, Leavenworth · 21 mi jauh
Umur 40 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05334069

Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

Mengambil pesertaFasa 1/2
  • University of Kansas Cancer Center, Kansas City
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Sep 2026 · NCT06287775

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

Mengambil pesertaFasa 1
  • University of Kansas Medical Center, Kansas City
Umur 18 ke atas · Semua jantina · Dikemas kini 3 Sep 2026 · NCT06343402

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Mengambil pesertaFasa 3
  • University of Kansas Cancer Center, Kansas City
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT05624996

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

Mengambil pesertaFasa 3
  • University of Kansas Cancer Center, Kansas City
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT06500481

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Mengambil pesertaFasa 1/2
  • The University of Kansas Cancer Center, Kansas City
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Ogo 2026 · NCT05592626

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Mengambil pesertaFasa 2
  • University of Kansas Cancer Center, Kansas City
Umur 18 ke atas · Semua jantina · Dikemas kini 3 Jun 2026 · NCT05642572

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Mengambil pesertaFasa 2/3
  • University of Kansas Cancer Center, Kansas City
  • Veteran Administration Eastern Kansas Healthcare, Leavenworth · 21 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Mei 2026 · NCT06616584

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Mengambil pesertaFasa 2
  • University of Kansas Cancer Center, Kansas City
18 Minutes · Semua jantina · Dikemas kini 5 Mei 2026 · NCT06031688

Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier

Mengambil pesertaKajian pemerhatian
  • University of Kansas Medical Center, Kansas City
Umur 29 hingga 85 · Semua jantina · Dikemas kini 13 Nov 2024 · NCT06426628

Using Ex Vivo Tumoroids To Predict Immunotherapy Response In NSCLC

Mengambil pesertaKajian pemerhatian
  • The University of Kansas Cancer Center, Westwood Campus, Kansas City
Umur 18 hingga 110 · Semua jantina · Dikemas kini 23 Feb 2024 · NCT05332925

Kajian Kanser Paru-paru di bandar lain

Kajian lain di Kansas City

Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.